The global embolotherapy market size reached USD 3.50 Billion in 2020 and is expected to register a revenue CAGR of 9.3%, during the forecast period, according to latest analysis by Emergen Research. Increasing prevalence of chronic diseases such as cancer, peripheral artery disease, and neurological disorders among others is a key factor driving global embolotherapy market revenue growth.

 

Rapid development of more advanced drug delivery systems such as drug-eluting beads is enabling radiologists to control drug release to tumors with reduced systemic drug exposure. This has also led to the development of new endovascular treatment procedures such as Drug-Elating Bead Transarterial Chemoembolization (DEB-TACE) procedure. The new procedure is based on the use of microspheres which release chemotherapeutic agents to targeted lesions with controlled amount of pharmacoketinics, thereby significantly improving clinical outcomes and reducing side-effects of embolotherapy treatment procedure.

 

For more Information or Any Query Visit: https://www.emergenresearch.com/industry-report/embolotherapy-market

The Universal Embolotherapy  Market report presents complete information covering insightful data for businesses and investors for the time period of 2020-2027. The report studies the historical data of the Embolotherapy  market and offers valuable information about the key segments and sub-segments, revenue generation, demand and supply scenario, trends, and other vital aspects. The report offers an accurate forecast estimation of the Embolotherapy  industry based on the recent technological and research advancements. It also offers valuable data to assist the investors in formulating strategic business investment plans and capitalize on the emerging growth prospects in the Embolotherapy  market.

The report, additionally, offers a comprehensive SWOT analysis and Porter’s Five Forces analysis to offer a better understanding of the competitive landscape of the industry. It also covers strategies adopted by prominent players such as mergers and acquisitions, collaborations, joint ventures, product launches, and brand promotions, among others. The report aims to offer the readers a holistic understanding of the relevant features of the industry.

Click here to Get customization https://www.emergenresearch.com/request-for-customization/763

Key Objectives of the Report:

  • Analysis and estimation of the Embolotherapy market size and share for the projected period of 2020-2028
  • Extensive analysis of the key players of the market by SWOT analysis and Porter’s Five Forces analysis to impart a clear understanding of the competitive landscape
  • Study of current and emerging trends, restraints, drivers, opportunities, challenges, growth prospects, and risks of the global Embolotherapy market
  • Analysis of the growth prospects for the stakeholders and investors through the study of the promising segments
  • Strategic recommendations to the established players and new entrants to capitalize on the emerging growth opportunities
  • Some major companies operating in the global market include Abbott Laboratories, Boston Scientific Corporation, Medtronic PLC, Terumo Medical Corporation, Penumbra Inc., Johnson & Johnson, Merit Medical Systems Inc., Cook Medical Inc., Kaneka Corporation, and Stryker Corporation.

The report further offers a complete value chain analysis along with an analysis of the downstream buyers and upstream raw materials. The study focuses on global trends, regulatory frameworks, and macro- and micro-economic factors. The report also provides an extensive analysis of the segment and sub-segmented expected to dominate the market over the projected period. The report offers a forecast estimation of the market with regards to the analysis of the market segmentation, including product type, end-user industries, application spectrum, and other segments.

Emergen Research has segmented the global embolotherapy market on the basis of product, procedure, application, end-use, and region:

  • Product Outlook (Revenue, USD Billion; 2018–2028)
  • Embolic Agents
    • Liquid Embolic Agents
    • Microspheres
  • Embolization Coils
    • Detachable Coils
    • Pushable Coils
  • Application Outlook (Revenue, USD Billion; 2018–2028)
    • Cancer
    • Peripheral Vascular Disease
    • Neurological Disease
    • Urological & Nephrological Disorders
    • Others
  • End-use Outlook (Revenue, USD Billion; 2018–2028)
    • Hospitals & Clinics
    • Ambulatory Surgical Centers
    • Others

Regional Analysis of the Embolotherapy  Market:

  • North America (U.S., Canada)
  • Europe (U.K., Italy, Germany, France, Rest of EU)
  • Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
  • Latin America (Chile, Brazil, Argentina, Rest of Latin America)
  • Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Thank you for reading our report. Please connect with us to know more about the report or for requesting the customization of the report. Our team will ensure the report is best suited to your requirements.

About Us:

At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: [email protected]

Facebook | LinkdIn | Twitter | Blogs